Literature DB >> 6997925

Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia.

L N Horowitz, M E Josephson, J A Kastor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6997925     DOI： 10.1016/0033-0620(80)90006-7

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  7 in total

1.  Electrophysiological testing after acute myocardial infarction.

Authors:  S M Cobbe
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

Review 2.  Assessment of the risk-benefit ratio for antiarrhythmic drug use.

Authors:  R W Campbell
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

4.  Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.

Authors:  Y Aizawa; M Chinushi; N Naitoh; A Shibata
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

Review 5.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

6.  Efficacy of phenytoin in suppressing inducible ventricular tachyarrhythmias.

Authors:  R N Fogoros; S B Fiedler; J J Elson
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

7.  A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.

Authors:  L J Jordaens; F Colardyn; D L Clement
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.